Impact of Antibiotic Therapy on the Upper Respiratory Tract and Gut Mycobiome in Patients with Cystic Fibrosis
Authors:
Open Access
- 28 August 2025
- journal article
- research article
- Published by MDPI AG in Journal of Fungi
- Vol. 11 (9) , 631
Abstract
Patients with cystic fibrosis (CF) are frequently exposed to antibiotic treatments, which can alter the fungal communities (mycobiome) across their mucosal sites. This pilot study investigated the impact of antibiotic exposure on the mycobiome by analyzing fungal community dynamics in the upper respiratory- (nasal lavage) and gastrointestinal- (stool samples) tracts of 12 patients with CF following (a) long-term antibiotic treatment over a three-year period and (b) short-term antibiotic therapy during acute pulmonary exacerbations. Mycobiome profiles of the samples obtained from 38 healthy individuals were also analyzed and used for comparison purposes. The ITS1 region of the fungal rRNA gene cluster was sequenced to characterize and quantify the fungal community composition in both cohorts. Compared to healthy controls, samples from the patients with CF who had undergone long-term antibiotic treatment revealed a significantly increased fungal biomass in both sino-nasal and stool samples. Moreover, diversity metrics revealed significant differences in nasal lavage samples, whereas the stool samples showed no significant variation. Candida spp. was significantly enriched in both nasal and stool samples from CF patients. Further analyses demonstrated a strong positive correlation between the relative abundance of Candida spp. and the cumulative antibiotic intake over the three-year period in sino-nasal samples, but not in stool samples. Acute antibiotic treatment during a pulmonary exacerbation episode also led to a marked increase in the abundance of Candida spp. in sino-nasal samples. These findings highlight the increased sensitivity of the sino-nasal mycobiome to both chronic and acute antibiotic exposure in CF patients, as characterized by a site-specific fungal overgrowth, particularly of Candida spp.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (390874280, 210879364)
- Jürgen Manchot Stiftung to RN (390874280, 210879364)
This publication has 82 references indexed in Scilit:
- Bronchoscopy in Cystic Fibrosis Infants Diagnosed by Newborn ScreeningPediatric Pulmonology, 2011
- Sputum Candida albicans Presages FEV1 Decline and Hospital-Treated Exacerbations in Cystic FibrosisChest, 2010
- Allergic Bronchopulmonary AspergillosisProceedings of the American Thoracic Society, 2010
- The Changing Microbial Epidemiology in Cystic FibrosisClinical Microbiology Reviews, 2010
- Persistence ofCandidaspecies in the respiratory tract of cystic fibrosis patientsMedical Mycology, 2010
- The antagonistic effect ofSaccharomyces boulardiionCandida albicansfilamentation, adhesion and biofilm formationFEMS Yeast Research, 2009
- Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesisThorax, 2007
- Presence of Fungus in Sinus Cultures of Cystic Fibrosis PatientsAmerican Journal of Rhinology, 2005
- Normal nasal mucociliary clearance in CF children: evidence against a CFTR‐related defectEuropean Respiratory Journal, 2004
- Clinical significance of the recovery ofAspergillus species from the respiratory secretions of cystic fibrosis patientsPediatric Pulmonology, 1996